• Your shopping cart is empty!
Ultima-Tesamorelin 2mg

Ultima-Tesamorelin 2mg

  • $46.00



MANUFACTURER Ultima Pharmaceuticals - US
WAREHOUSE USA Warehouse 5
SUBSTANCE GHRH Peptide ,

Products are shipped without branding for security purposes.

Tesamorelin is formulated with a growth hormone-releasing factor (GRF).

This medication is used to help decrease excess abdominal fat resulting from certain HIV treatments, a condition often referred to as lipodystrophy.

It is important to note that Tesamorelin is not intended for weight loss and should not be utilized to manage obesity.

Tesamorelin (for injection) is specifically indicated for the reduction of extra abdominal fat in HIV-infected individuals suffering from lipodystrophy.

Restrictions on Use:

  • The long-term cardiovascular safety and benefits of Tesamorelin have not been researched, so it is crucial to carefully evaluate the continuation of Tesamorelin treatment in patients who do not exhibit a significant response, as assessed by a decrease in visceral fat measured through waist circumference or CT imaging.
  • Tesamorelin is not approved for weight loss (it has a weight-neutral effect).
  • There is no evidence indicating that Tesamorelin improves adherence to antiretroviral treatments in HIV-positive patients.

    • General Dosage Guidelines:

    The recommended dosage of Tesamorelin is 2 mg, administered subcutaneously once daily.

    The preferred injection site is the abdomen, and it is advisable to rotate injection sites within different areas of the abdomen. Avoid injecting into areas with scar tissue, bruises, or near the navel.

    Reconstitution Instructions:

    Tesamorelin should be reconstituted with the diluent included with the medication.

    For reconstitution, combine the 2 mg vial of Tesamorelin with 2.1 mL of the diluent. Gently roll the vial in your hands for 30 seconds to mix; do not shake.

    Comprehensive reconstitution instructions can be found in the INSTRUCTIONS FOR USE leaflet included with the Tesamorelin and diluent packaging.

    Administer Tesamorelin right after reconstitution, and dispose of any leftover solution. If not used immediately, discard the reconstituted solution. Never freeze or refrigerate the reconstituted Tesamorelin.

    Administration:

    Before administration, visually inspect the reconstituted Tesamorelin solution for any particulate matter or discoloration; it should only be injected if it is clear, colorless, and free of particulate matter.

    Inject Tesamorelin subcutaneously into the skin of the abdomen, remembering to rotate injection sites. Avoid areas with scar tissue, bruises, or near the navel.